Copaxone demonstrates remyelination & neuroprotective effect

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Copaxone demonstrates remyelination & neuroprotective effect

Postby MSUK » Thu Oct 20, 2011 12:30 am

Image

Teva Pharmaceutical Industries Ltd. today announced preclinical data demonstrating reparative and neuroprotective effects of treatment with Copaxone(R) (glatiramer acetate injection) in experimental autoimmune encephalomyelitis (EAE) models. In the study, researchers compared mice treated with Copaxone(R) versus non-treated mice in relapsing-remitting and chronic multiple sclerosis (MS) disease models. Researchers observed both remyelination indicative of repair and a drastic reduction of demyelination and axonal loss in mice treated with Copaxone(R).... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1767
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2176
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Copaxone

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service